Multimodal imaging also known as multiplexed imaging is a combination of imaging modalities for offering better images by overcoming the limitations of independent imaging techniques. It includes techniques such as magnetic resonance imaging, positron emission tomography, and computed tomography. It plays a significant role in identifying, diagnosing, and managing patients with varied diseases. Multimodality imaging is a new emerging hybrid imaging platform that utilizes the strength of different modalities for its usage in advanced biomedical technology, molecular biology, and imaging sciences. 

Advancements in multimodality imaging have resulted in greater adoption of multimodality imaging systems in the world. For instance, in March 2019, Siemens Healthineers announced their first installation of Biograph Vision positron emission tomography/computed tomography (PET/CT) systemat the Hospital of the University of Pennsylvania in Philadelphia. 

Rise in usage of multimodality imaging techniques in radiotherapy and increase in drug discovery and surgical interventions drive the growth of the multimodal imaging market. Furthermore, increase in usage of multimodal imaging for ophthalmology and diagnosis & treatment of malignant tumors, cancers & neurological disorders further drive the market growth. As per CDC, the estimated number of new cancer cases and deaths in 2019 were 1,762,450 and 606,880, respectively, in the U.S.In addition, as per the WHO, it is estimated that at least 2.2 billion people have a vision impairment or blindness. This increase in cancer incidences and eye disease disorders across the worldpropel the screening and diagnosing of cancer through multimodal imaging techniques. However, lack of adequate healthcare infrastructure and high costs of multimodal imaging systems are expected to restrain the growth of the multimodal imaging market. Moreover, lack of highly skilled professionals is expected to hinder the market globally. On the contrary, developments in multimodality techniques with the help of fluorescence imaging probes for detection of diseasesand use of multimodality imaging techniques in nanomedicine & nanotheranostics for tumor diagnosis are anticipated to provide lucrative opportunities for the growth of the market. 

The multimodal imaging market is classified on the basis of technology, application, enduser, and region. Based on technology, the multimodal imaging market is divided into PET/CT systems, SPECT/CT systems, PET/MR systems, OCT/fundus imaging systems, and other multimodal imaging systems. By application, the market is classified into brain & neurology, cardiology, oncology, ophthalmology, and other applications. Based on end user, it is categorized into hospitals, diagnostic imaging centers, and other end users. Region wise, it is studied acrossNorth America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the multimodal imaging market include Koninklijke Philips N.V., Siemens Healthineers, United Imaging Healthcare Co., Ltd., GE Healthcare, Topcon Corporation, Canon, Inc., Heidelberg Engineering, Infraredx, Inc., Mediso Medical,and Imaging Systems Kft. Some of the other players operating in the market are Spectrum Dynamics Medical, Optos Plc, Kowa Company, Ltd., Optovue, Inc., Neusoft Medical Systems Co., Ltd., Nidek Co., Ltd, andCarl Zeiss AG.The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their geographical presence through partnerships and increase in investment for advancement of imaging systems.

Key Benefits For Stakeholders

• This report provides a detailed quantitative analysis of the current market trends and multimodal imaging market forecast estimations from 2019 to 2027, which assists to identify the prevailing opportunities. 

• An in-depth multimodal imaging market analysisincludes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

• A comprehensive analysis of the factors that drive and restrain the growth of the multimodal imaging market is provided.

• Region-wise and country-wise market conditions are comprehensively analyzed in this report.

• The projections in this report are made by analyzing the currentmultimodal imaging market trends and future market potential from2019 to 2027 in terms of value.

• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

• The key multimodal imaging market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.

Key Market Segments

By Technology

• PET/CT Systems
• SPECT/CT Systems
• PET/MR Systems
• OCT/Fundus Imaging Systems
• Other Multimodal Imaging Systems

By Application

• Brain & Neurology
• Cardiology
• Oncology
• Ophthalmology
• Other Applications

By End User

• Hospitals
• Diagnostic Imaging Centers
• Other End Users

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA